6-Chloro-9-(THP)Purine Drop-In Replacement | CAS 7306-68-5
Trace Impurity Profiles: Residual THP-Protected Byproducts vs. Deprotected 6-Chloropurine in COA Parameters
Engineering analysis of impurity profiles is critical for this THP protected purine. The Certificate of Analysis (COA) must rigorously distinguish between residual THP-protected byproducts and deprotected 6-chloropurine. The tetrahydropyran (THP) group serves as an acid-labile protecting group for the N9 position of the purine ring. In the synthesis of this Chloropurine derivative, the integrity of the ether linkage is paramount. Field experience indicates that during the workup phase, exposure to acidic aqueous washes can lead to partial deprotection if pH control is not precise. This results in the formation of deprotected 6-chloropurine, which exhibits different solubility characteristics and can co-crystallize with the protected species, complicating purification.
Furthermore, trace levels of deprotected species, often below standard detection limits, can catalyze oligomerization during high-temperature coupling reactions. We have observed that these trace impurities can cause unacceptable color shifts in the final API, manifesting as yellowing during nucleophilic substitution steps. Our manufacturing protocol ensures strict control over acid-labile cleavage points, maintaining the integrity of the tetrahydropyran group. Please refer to the batch-specific COA for exact impurity thresholds and chromatographic separation details.
Comparing HPLC Peak Retention Times & Heavy Metal Limits (≤20ppm) to Prevent Palladium Catalyst Poisoning
For R&D managers validating this Heterocyclic building block, HPLC peak retention time consistency is the primary metric for batch equivalence. Variations in retention time often indicate structural isomers or incomplete protection, which can disrupt stoichiometric calculations in automated synthesis workflows. Our analytical methods are calibrated to match the retention time profiles of reference standards, ensuring seamless integration into existing quality control protocols.
Heavy metal contamination poses a severe risk in downstream Suzuki-Miyaura couplings. Trace metals such as copper or iron can adsorb onto palladium active sites, leading to catalyst deactivation and reduced turnover numbers. Our process controls heavy metals to prevent palladium catalyst poisoning, maintaining limits suitable for sensitive cross-coupling reactions. The following table outlines key technical parameters for validation purposes.
| Parameter | Specification | Relevance to Drop-In Replacement |
|---|---|---|
| HPLC Retention Time | Please refer to batch-specific COA | Must match reference standard for ChemImpEx 30035 / USBio 234640 |
| Heavy Metals | ≤20ppm | Prevents Pd catalyst deactivation in cross-coupling |
| Residual Solvents (DMF/THF) | Please refer to batch-specific COA | Impact on crystallization and downstream yield |
| Purity (HPLC) | Please refer to batch-specific COA | Ensures stoichiometric accuracy in synthesis |
Field observation regarding thermal stability: During bulk storage in unclimatized warehouses, slight temperature fluctuations can induce partial solvent retention changes, affecting dissolution rates. We recommend maintaining storage below 25°C to prevent any thermal stress on the THP ether linkage and to ensure consistent dissolution behavior during reaction setup.
Purity Grade Specifications & Downstream Nucleophilic Substitution Yields in PI3K Inhibitor Synthesis
This compound serves as a critical intermediate for Purine nucleoside analog development, particularly in PI3K inhibitor synthesis. The nomenclature 6-chloro-9-(oxan-2-yl)purine is chemically equivalent and often used interchangeably in literature. Purity directly correlates with nucleophilic substitution yields. Impurities can compete for the nucleophile or block the C6 position, leading to reduced conversion rates and difficult purification of the target intermediate.
In the synthesis of Idelalisib intermediates, the C6 chlorine is the reactive center for displacement by amines or heterocycles. Our drop-in replacement maintains identical purity profiles to ensure yield consistency without re-optimization. Edge-case analysis reveals that during large-scale nucleophilic substitutions, trace water content in the starting material can hydrolyze the THP group prematurely. This leads to a mixture of protected and deprotected species that complicates purification and reduces overall yield. Our drying protocols ensure water content is minimized to support high-yield substitutions and maintain the structural integrity required for sensitive downstream transformations.
Bulk Packaging Protocols & Technical Data Validation for ChemImpEx 30035 & USBio 234640 Drop-in Replacement
NINGBO INNO PHARMCHEM CO.,LTD. provides a seamless 6-Chloro-9-(tetrahydropyran-2-yl)purine drop-in replacement for ChemImpEx 30035 and USBio 234640. Procurement managers benefit from enhanced supply chain reliability and cost-efficiency without compromising technical parameters. Our manufacturing capacity supports consistent bulk supply, reducing lead times and mitigating risks associated with single-source dependencies.
Packaging is strictly physical to ensure material integrity during transit. Standard configurations include 25kg IBCs or 210L drums equipped with nitrogen blanketing to prevent moisture ingress and oxidation. Field data regarding winter shipping indicates that in regions with sub-zero transit temperatures, the material may exhibit increased hardness or caking due to solvent crystallization. This is a physical state change, not degradation. Standard re-dissolution protocols apply. We recommend insulated packaging for transit below -10°C to maintain free-flowing powder characteristics and facilitate efficient handling upon receipt.
Frequently Asked Questions
How does batch-to-batch HPLC consistency compare to reference standards?
Our manufacturing process ensures tight control over HPLC retention times and peak purity. Each batch is validated against reference standards to guarantee consistency equivalent to ChemImpEx 30035 and USBio 234640. Please refer to the batch-specific COA for detailed chromatograms and quantitative analysis.
What are the acceptable residual solvent limits for DMF and THF?
Residual solvent levels are strictly monitored to prevent interference in downstream reactions. Limits for DMF and THF are controlled within acceptable ranges for pharmaceutical intermediates. Exact values are provided in the batch-specific COA to support your quality assurance protocols.
Can this product be used as a direct substitution without re-optimizing reaction conditions?
Yes. This product is engineered as a drop-in replacement with identical technical parameters. R&D teams can substitute this material directly into existing protocols for PI3K inhibitor synthesis or nucleophilic substitutions without re-optimizing reaction conditions.
Sourcing and Technical Support
NINGBO INNO PHARMCHEM CO.,LTD. supports procurement and R&D teams with technical data validation and reliable supply of this critical intermediate. Our engineering team is available to assist with batch validation and integration queries. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.